How much does Sotorasib cost?

Sotorasib (Sotorasib) is a cancer drug used to treat adults with advanced non-small cell lung cancer (NSCLC) whose cells have specific genetic changes. This change occurs in the KRAS gene and is called "KRAS G12C." When the disease progresses after systemic therapy (treatment that affects the entire body), doctors give sotorasib as treatment. Sotorasib contains the active substance sotorasib.

Genetic changes in the KRAS gene can produce an altered protein that leads to uncontrolled growth of cancer cells. The active substance in sotorasibsotorasib attaches to this altered protein in cancer cells. This prevents the protein from working, interrupting the chemical messages cancer cells need to grow and spread, and also promotes processes that lead to cancer cell death.

SotoracibThe original drug has not yet been launched in China, so it is not covered by medical insurance. Domestic patients cannot yet purchase this drug. The price of Hong Kong original research versionsotorasibuSpecifications120mg*240 tablets is about RMB 80,000, and the European original research version 120mg*240 tablets is priced at about RMB 44,040 (the price may fluctuate due to the exchange rate), which is relatively expensive. There are also cheaper generic drugs for sale in other countries. The specifications of the Laos Element Pharmaceutical Factory are 120mg*56 tablets and the price is around 4800 yuan (the price may fluctuate due to the exchange rate). The price is relatively cheap. The ingredients of foreign generic drugs are basically the same as the original drugs.